Financial

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist,…

12 hours ago

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision…

3 days ago

Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology, Helping People Take Action Earlier to Slow Disease Impact

Findings show Linus Health's AI can indicate Alzheimer's pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve…

3 days ago

Neuraxpharm Goes Live with TraceLink MINT to Standardize Real‑Time Data Exchange Across Its Global Supply Chain Network

The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestrationBOSTON, Dec. 18, 2025 /PRNewswire/…

4 days ago

Neuraxpharm Goes Live with TraceLink MINT to Standardize Real‑Time Data Exchange Across Its Global Supply Chain Network

The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestrationBOSTON, Dec. 18, 2025 /PRNewswire/…

4 days ago

Century Health and Tessel Biosciences Collaborate to Apply AI-Curated Real World Data to Advance Early Drug Development in COPD

Despite decades of research, many COPD subpopulations remain poorly understood in real-world settings and underserved by existing therapiesUsing AI to…

4 days ago

Century Health and Tessel Biosciences Collaborate to Apply AI-Curated Real World Data to Advance Early Drug Development in COPD

Despite decades of research, many COPD subpopulations remain poorly understood in real-world settings and underserved by existing therapiesUsing AI to…

4 days ago

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

AI-powered drug discovery and biodefense company engages pharma on CNS programs amid rising deal activitySACRAMENTO, Calif., Dec. 18, 2025 /PRNewswire/…

4 days ago

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

AI-powered drug discovery and biodefense company engages pharma on CNS programs amid rising deal activitySACRAMENTO, Calif., Dec. 18, 2025 /PRNewswire/…

4 days ago

NetraMark Delivers Transformational Quarter Of Execution

Contract Backlog Expands to C$2.5M, FDA CPIM Completed, Nature Portfolio Study Accepted, Major Channel Partner Onboarding, and CAMH Research Award…

4 days ago